HSII(HSII)
HSII
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.22B | $1.31B |
| Low | $1.15B | $1.27B |
| High | $1.26B | $1.33B |
| EBITDA Avg | $131M | $141M |
| Low | $123M | $136M |
| High | $135M | $143M |
| EBIT Avg | $105M | $113M |
| Low | $99M | $109M |
| High | $108M | $115M |
| Net Income Avg | $74M | $85M |
| Low | $70M | $83M |
| High | $78M | $88M |
| EPS Avg | $3.53 | $4.05 |
| Low | $3.29 | $3.89 |
| High | $3.70 | $4.14 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $321M | $299M | $303M | $340M | $339M | $318M |
| Low | $321M | $299M | $303M | $340M | $339M | $318M |
| High | $321M | $299M | $303M | $340M | $339M | $318M |
| EBITDA Avg | $34M | $32M | $33M | $36M | $36M | $34M |
| Low | $34M | $32M | $33M | $36M | $36M | $34M |
| High | $34M | $32M | $33M | $36M | $36M | $34M |
| EBIT Avg | $28M | $26M | $26M | $29M | $29M | $27M |
| Low | $28M | $26M | $26M | $29M | $29M | $27M |
| High | $28M | $26M | $26M | $29M | $29M | $27M |
| Net Income Avg | $21M | $18M | — | — | — | — |
| Low | $21M | $18M | — | — | — | — |
| High | $21M | $18M | — | — | — | — |
| EPS Avg | $1.00 | $0.83 | — | — | — | — |
| Low | $1.00 | $0.83 | — | — | — | — |
| High | $1.00 | $0.83 | — | — | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — | 1 / — |